The major modulations were observed in the CD56+ cell subsets, where an increase in the expression of CD49a, CD94 and NKp44 alongside a decrease in the activating receptor CD16 and in GzmB expression characterized CIS/IC-infiltrating cells (Figure 4). Here, NCAM1 is linked to in situ carcinoma.